Preventing ship collisions with technology
The end of food waste as we know it?
How millennials are transforming the drinks industry
How the energy sector is improving gender diversity
We speak to Elena Bou, innovation director at InnoEnergy, about how the energy transition can help with gender diversity.
How gaming tech is being used to medically train astronauts
Medical Technology looks at how gaming tech is being used to medically train astronauts for deep space missions.
Fixing the pharma industry’s image problem
The pharma industry’s reputation isn’t great , so how can PR help to fix the industry’s image problem? Pharma Technology Focus investigates.
The women fighting for equality in the maritime sector
How ports are preparing for climate change
Explansion plans for the Port of Vancouver have drawn criticism for failing to account for climate change. But just how can ports be future-proofed aganist rising sea levels and extreme weather conditions? Ross Davies finds out in the latest issue of Ship Technology Global.
A new president and a new direction for Peru’s mining sector
Peru’s new President Martín Vizcarra claims to be pro-development and anti ‘bad mining’ – trying to strike a delicate balance of economy and environment. So what’s in store for this mining-dependent country and how does he plan to transform the sector? Heidi Vella investigates in the latest issue of MINE.
Migrant crisis: airports are caught in the middle but how can they help?
The modern surge of migration, driven by those seeking economic opportunity or fleeing from war or persecution, is a defining geopolitical issue of our time. In the latest issue of AIR, Chris Lo investigates how it is affecting airports and whether they can become part of the solution.
Will the FDA’s name and shame tactic help speed up generic drug developement?
The US Food and Drug Administration has publicly listed the names of nearly 40 pharma companies that may have been denying access to reference samples for generic drug manufacturers, thereby delaying generic competition. Is this ‘name and shame’ strategy justified, and just how big is the issue of pharma companies holding back reference samples from generic competitors after patent expiry? Chris Lo investigates in the latest issue of Pharma Technology Focus
America’s Triton drones and the race to get a handle on the South China Sea
The US is deploying MQ-4C Triton drones to Guam to assist with surveillance in the South China Sea, where the battle for strategic supremacy with China threatens to escalate into direct confrontation. Julian Turner assesses the situation and asks what the drones will add to the US military’s arsenal in the Pacific.
A sense of luxury: how to hit the right note with high-end spirit packaging design
Whether the consumer is sipping on a luxury spirit or admiring a vintage whisky, brands need to be able to cater to an audience that expects high quality. Jasmine Lee-Zogbessou looks at the recent redesign of French Brandy St-Rémy to find out more about the challenges of finding the right packaging for high-end spirits.
Does Heathrow’s environmental mitigation strategy hold up?
After a controversial national debate, Heathrow Airport has received backing for its third runway project. The airport has gone to great lengths to prove it is embarking on a journey to sustainable growth, but is its environmental strategy convincing enough? Eva Grey reports.
Capitalising on the free from trend
Free from products and ingredient supplements have become a staple feature of major retailers, but as the trend develops, how can brands capitalise on the movement? Eloise McLennan sums up key insights and advice from GlobalData’s most recent analysis of the free from market in the latest issue of Inside Food.
US approval for Epidiolex fuels new hope for cannabinoid-based medicines
In June the US Food and Drug Administration approved the country’s first cannabinoid-based drug, Epidiolex, for treating seizures in two forms of severe epilepsy. Abi Millar asks what this milestone will mean for other cannabinoid-based medicines being developed in the country.
The $1 trillion dollar question: who can afford to fly the F-35?
The US Air Force is reportedly considering cancelling orders for as many as 590 F-35 Lightning II fighter jets because the aircraft is proving too expensive to operate and maintain. Julian Turner reports on the controversy and whether ongoing cost issues will affect purchase commitments.